Merck’s colorectal cancer therapy fails late-stage trial

(Reuters) – Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of colorectal cancer.

(Reporting by Christy Santhosh; Editing by Varun H K)